SOBR Safe, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' DEFICIT

CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' DEFICIT (USD $)	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Stockholders' Equity - TransBiotec Inc.	Noncontrolling Interest	Total
Biginning Balance, Amount at Dec. 31, 2012	$ 303	$ 11,903,279	$ (14,274,244)	$ (2,370,662)	$ (25,629)	$ (2,396,291)us-gaap_StockholdersEquity
Beginning Balance, Shares at Dec. 31, 2012	30,315,554
Stock issued for cash, Amount
Stock issued for services, Shares	833,333
Stock issued for services, Amount	9	77,424		77,433		77,433IMLE_StockIssuedForServicesAmount
Stock conversion of note payable , Shares	2,997,825
Stock conversion of note payable, Amount	30	48,970		49,000		49,000IMLE_StockConversionOfNotePayableAmount
Paid in capital - beneficial conversion feature		76,951		76,951		76,951
Paid in capital - stock option expense		145,997		145,997		145,997IMLE_PaidInCapitalStockOptionExpense
Paid in capital - Equity obligation settlement at fair value		163,018		163,018		163,018
Share exchange - noncontrolling interest					(4,791)	(4,791)
Net Loss			(758,416)	(758,416)		(758,416)IMLE_NetLoss
Ending Balance, Amount at Dec. 31, 2013	342	12,415,639	(15,032,660)	(2,616,679)	(30,420)	(2,647,099)us-gaap_StockholdersEquity
Ending Balance, Shares at Dec. 31, 2013	34,146,712
Stock issued for services, Shares	154,520
Stock issued for services, Amount	2	3,057		3,059		3,059IMLE_StockIssuedForServicesAmount
Stock conversion of note payable , Shares	24,115,428
Stock conversion of note payable, Amount	241	66,878		67,119		67,119IMLE_StockConversionOfNotePayableAmount
Paid in capital - beneficial conversion feature		15,000		15,000		15,000
Paid in capital - stock option expense		69,886		69,886		69,886IMLE_PaidInCapitalStockOptionExpense
Paid in capital - Equity obligation settlement at fair value		146,170		146,170		146,170
Share exchange - noncontrolling interest					(4,367)	(4,367)
Net Loss			(744,562)	(744,562)		(744,562)IMLE_NetLoss
Ending Balance, Amount at Dec. 31, 2014	$ 585	$ 12,716,630	$ (15,777,222)	$ (3,060,007)	$ (34,787)	$ (3,094,794)us-gaap_StockholdersEquity
Ending Balance, Shares at Dec. 31, 2014	58,416,660